BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 7958908)

  • 1. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
    Hann SR; Dixit M; Sears RC; Sealy L
    Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
    Swanson HI; Yang JH
    Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
    Hurlin PJ; Quéva C; Eisenman RN
    Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.
    Fisher F; Crouch DH; Jayaraman PS; Clark W; Gillespie DA; Goding CR
    EMBO J; 1993 Dec; 12(13):5075-82. PubMed ID: 8262050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
    EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite orientations of DNA bending by c-Myc and Max.
    Wechsler DS; Dang CV
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7635-9. PubMed ID: 1323849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE; Shor J; Kahana C
    Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ; Gubbels JM; Bernards R; van der Vliet PC; Timmers HT
    Nucleic Acids Res; 1997 Apr; 25(8):1493-501. PubMed ID: 9162900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
    Arsura M; Deshpande A; Hann SR; Sonenshein GE
    Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
    Gu W; Cechova K; Tassi V; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Amati B; Dalton S; Brooks MW; Littlewood TD; Evan GI; Land H
    Nature; 1992 Oct; 359(6394):423-6. PubMed ID: 1406955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.